Relieving bottlenecks in RNA drug discovery for retinal diseases.
about
Effects of Pathogenic Variations in the Human Rhodopsin Gene (hRHO) on the Predicted Accessibility for a Lead Candidate Ribozyme.The biomarker and therapeutic potential of miRNA in Alzheimer's disease.A cellular high-throughput screening approach for therapeutic trans-cleaving ribozymes and RNAi against arbitrary mRNA disease targets.Viroid research and its significance for RNA technology and basic biochemistry
P2860
Relieving bottlenecks in RNA drug discovery for retinal diseases.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Relieving bottlenecks in RNA drug discovery for retinal diseases.
@en
Relieving bottlenecks in RNA drug discovery for retinal diseases.
@nl
type
label
Relieving bottlenecks in RNA drug discovery for retinal diseases.
@en
Relieving bottlenecks in RNA drug discovery for retinal diseases.
@nl
prefLabel
Relieving bottlenecks in RNA drug discovery for retinal diseases.
@en
Relieving bottlenecks in RNA drug discovery for retinal diseases.
@nl
P2093
P2860
P1476
Relieving bottlenecks in RNA drug discovery for retinal diseases.
@en
P2093
Edwin H Yau
Jack M Sullivan
Mark C Butler
R Thomas Taggart
Tiffany A Kolniak
P2860
P304
P356
10.1007/978-1-4614-0631-0_20
P407
P577
2012-01-01T00:00:00Z